Risk factors for non-compliance with continuous positive airway pressure therapy in patients with obstructive sleep apnea and paroxysmal atrial fibrillation

G. Traaen (Oslo, Norway), M. Vik-Strandli (Oslo, Norway), B. Øverland (Oslo, Norway), L. Aakerøy (Trondheim, Norway), T. Hunt (Oslo, Norway), C. Bendz (Oslo, Norway), N. Bredesen (Trondheim, Norway), L. Sande (Oslo, Norway), S. Aakhus (Trondheim, Norway), S. Steinshamn (Trondheim, Norway), O. Anfinsen (Oslo, Norway), J. Loennechen (Trondheim, Norway), H. Akre (Oslo, Norway), L. Gullestad (Oslo, Norway)

Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Session: Advance in treatments for sleep and breathing disorders and long-term adherence
Session type: E-poster session
Number: 2489
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Traaen (Oslo, Norway), M. Vik-Strandli (Oslo, Norway), B. Øverland (Oslo, Norway), L. Aakerøy (Trondheim, Norway), T. Hunt (Oslo, Norway), C. Bendz (Oslo, Norway), N. Bredesen (Trondheim, Norway), L. Sande (Oslo, Norway), S. Aakhus (Trondheim, Norway), S. Steinshamn (Trondheim, Norway), O. Anfinsen (Oslo, Norway), J. Loennechen (Trondheim, Norway), H. Akre (Oslo, Norway), L. Gullestad (Oslo, Norway). Risk factors for non-compliance with continuous positive airway pressure therapy in patients with obstructive sleep apnea and paroxysmal atrial fibrillation. 2489

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of continuous positive airway pressure in patients with paroxysmal atrial fibrillation and obstructive sleep apnea
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Risk factors for the development of malignant arrhythmias in patients with obstructive sleep apnea and systolic ventricular dysfunction
Source: International Congress 2019 – Challenging issues in the clinical aspects of sleep-disordered breathing
Year: 2019




Is obstructive sleep apnoea related to incident atrial fibrillation?
Source: ISSN=ISSN 1810-6838, ISBN=, page=379
Year: 2007

Prevalence and clinical predictors of sleep apnea in patients with paroxysmal atrial fibrillation
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019


CPAP and atrial overdrive pacing in the treatment of obstructive sleep apnea syndrome
Source: Annual Congress 2004 - CPAP therapy for OSA
Year: 2004


Relationship between obstructive sleep apnoea (OSA) and atrial fibrillation
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009

Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome
Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea
Year: 2006

No benefit of overdrive atrial pacing for treatment of obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 23s
Year: 2003

Prevalence of atrial fibrillation (AF) in obstructive sleep apnea patients (OSA). Preliminary results
Source: Eur Respir J 2007; 30: Suppl. 51, 331s
Year: 2007

Can peripheral saturation predict the existence of obstructive sleep apnea syndrome (OSA) in a population followed for atrial fibrillation (AF)?
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019


STOP-Bang and Berlin questionnaire as predictors of sleep apnea in patients with paroxysmal atrial fibrillation
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019


Effects of CPAP on right ventricular myocardial performance index in obstructive sleep apnea patients without hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 816s
Year: 2006

Prevalence and predictors of arrhythmia in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011


Nocturnal overdrive pacing in pacemaker patients with obstructive sleep apnea
Source: Annual Congress 2004 - Non-CPAP therapy for OSA
Year: 2004


Right ventricular remodeling in obstructive sleep apnea patients
Source: Virtual Congress 2020 – New insights into sleep apnoea: from diagnosis to treatment
Year: 2020


Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008


Predictors of continuous positive airway pressure adherence in obstructive sleep apnea syndrome
Source: International Congress 2017 – Inhalers and their use
Year: 2017


Effects of CPAP on blood pressures and left ventricular structure in male patients with obstructive sleep apnea
Source: Eur Respir J 2006; 28: Suppl. 50, 816s
Year: 2006

Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012


Short-term effect of nCPAP on left ventricular diastolic filling in patients with obstructive sleep apnea
Source: Eur Respir J 2006; 28: Suppl. 50, 816s
Year: 2006